IBRX
ImmunityBio, Inc.Healthcare$7.30
▲ Bullish
Mkt Cap: $7.54B|Float: 379.5M|SI: 35.4%|DTC: 3.3
Data as of market close Apr 2, 2026
IV Rank
0
IV Pctl
0%
HV 20d
126.6%
52W Range
$2-$12
ATR(14)
$0.97
Exp. Move
±17.1%
P/C Ratio
0.46
Earnings
May 11
GEX Positive
DEX Long
Net Put Premium
IV Low
Max Pain Above
Exp. Move Wide
Low Put/Call
IBRX Key Options Data
- IV Rank
- 0%
- Total GEX
- $0.01B
- Total DEX
- $25.9M
- Max Pain
- $8.00
- Expected Move
- ±17.1%
- Put/Call OI
- 0.46
- Net Premium
- $-0.8M
- Spot Price
- $7.30
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$1.25 | ±17.1% | $6.05 | $8.55 |
| 2026-04-17 | 15 | ±$1.30 | ±17.8% | $6.00 | $8.60 |
| 2026-04-24 | 22 | ±$1.88 | ±25.7% | $5.43 | $9.18 |
| 2026-05-01 | 29 | ±$2.20 | ±30.1% | $5.10 | $9.50 |
| 2026-05-08 | 36 | ±$0.95 | ±13.0% | $6.35 | $8.25 |
| 2026-05-15 | 43 | ±$2.53 | ±34.6% | $4.78 | $9.83 |
Explore IBRX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.